Home Cart Sign in  
Chemical Structure| 1263373-43-8 Chemical Structure| 1263373-43-8

Structure of NVP-2
CAS No.: 1263373-43-8

Chemical Structure| 1263373-43-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

NVP-2 is a potent, selective, ATP-competitive CDK9 probe that inhibits CDK9/CycT activity with an IC50 of 0.514 nM. It also inhibits CDK1/CycB, CDK2/CycA, and CDK16/CycY kinases with IC50 values of 0.584 µM, 0.706 µM, and 0.605 µM, respectively, and induces cell apoptosis.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of NVP-2

CAS No. :1263373-43-8
Formula : C27H37ClN6O2
M.W : 513.07
SMILES Code : N#CC1(CNC2=CC=CC(C3=CC(N[C@H]4CC[C@H](N[C@H](C)COC)CC4)=NC=C3Cl)=N2)CCOCC1
MDL No. :MFCD28385769
InChI Key :XWQVQSXLXAXOPJ-QNGMFEMESA-N
Pubchem ID :66937006

Safety of NVP-2

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H312-H332
Precautionary Statements:P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Related Pathways of NVP-2

Hedgehog

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
U937 cells 12.15 nM (IC50) 24 hours Inhibited U937 cell viability Cancer Biol Ther. 2025 Dec;26(1):2450859
Kasumi-1 cells 10.02 nM (IC50) 24 hours Inhibited Kasumi-1 cell viability Cancer Biol Ther. 2025 Dec;26(1):2450859
U937 cells 20 nM 12 hours RNA-seq analysis showed CDK9 inhibition affects cell cycle and apoptosis-related genes Cancer Biol Ther. 2025 Dec;26(1):2450859
U937 cells 15 nM NVP-2 + 25 µM Orlistat 16 hours Induced apoptosis and G1 phase cell cycle arrest Cancer Biol Ther. 2025 Dec;26(1):2450859
Kasumi-1 cells 15 nM NVP-2 + 20 µM Orlistat 16 hours Induced apoptosis and G1 phase cell cycle arrest Cancer Biol Ther. 2025 Dec;26(1):2450859
BNFmut melanoma cells 500 nM 24 hours To evaluate the inhibitory effect of NVP-2 on BNFmut melanoma cells, results showed that BNFmut cells were less sensitive to NVP-2 with minimal cell death. J Invest Dermatol. 2021 Aug;141(8):2018-2027.e4.
BNFwt melanoma cells 500 nM 24 hours To evaluate the inhibitory effect of NVP-2 on BNFwt melanoma cells, results showed that BNFwt cells were more sensitive to NVP-2 with significantly increased cell death. J Invest Dermatol. 2021 Aug;141(8):2018-2027.e4.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.95mL

0.39mL

0.19mL

9.75mL

1.95mL

0.97mL

19.49mL

3.90mL

1.95mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories